Loading...
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
Immune checkpoint therapy has resulted in remarkable improvements in the outcome for certain cancers. To broaden the clinical impact of checkpoint targeting, we devised a strategy that couples targeting of the cytokine-inducible Src homology 2–containing (CIS) protein, a key negative regulator of in...
Saved in:
| Published in: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869185/ https://ncbi.nlm.nih.gov/pubmed/32902645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007748 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|